Detalles de la búsqueda
1.
Comparison of minimal residual disease measurement by multicolour flow cytometry and PCR for fusion gene transcripts in infants with acute lymphoblastic leukaemia with KMT2A gene rearrangements.
Br J Haematol
; 201(3): 510-519, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34970734
2.
Genetic characteristics and treatment outcome in infants with KMT2A germline B-cell precursor acute lymphoblastic leukemia: Results of MLL-Baby protocol.
Pediatr Blood Cancer
; 70(4): e30204, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36715125
3.
Incidence and prognostic value of central nervous system involvement in infants with B-cell precursor acute lymphoblastic leukemia treated according to the MLL-Baby protocol.
Pediatr Blood Cancer
; 69(9): e29860, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35713168
4.
Reduced vs. standard dose native E. coli-asparaginase therapy in childhood acute lymphoblastic leukemia: long-term results of the randomized trial Moscow-Berlin 2002.
J Cancer Res Clin Oncol
; 145(4): 1001-1012, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30840197
5.
Combination of chemotherapy and all-trans retinoic acid for the treatment KMT2A-rearranged infant acute lymphoblastic leukemia. Results of the MLL-Baby trial.
Leukemia
; 37(11): 2276-2281, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37741948
Resultados
1 -
5
de 5
1
Próxima >
>>